Skip to main content

Talphera, Inc.

TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427925

No open-market purchases or sales by Talphera, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $24.6M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Talphera, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of TLPH: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders5660+4
Shares19.9M17.1M−2.75M (−13.9%)
Value$5.66M$4.18M−$1.48M (−26.2%)

New holders (10)

Institutions that held Talphera, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to TLPH in Q2 2022
InstitutionSharesValue% of portfolio
Charles Schwab Investment Management Inc127,639$32.0K0.00%
Virtu Financial LLC119,460$29.0K0.00%
Kovack Advisors, Inc.50,000$12.0K0.00%
Avantax Advisory Services, Inc.44,000$11.0K0.00%
Cerity Partners LLC20,300$5.00K0.00%
Paragon Capital Management Ltd20,000$5.00K0.00%
Mercer Global Advisors Inc15,200$4.00K0.00%
LPL Financial LLC11,400$3.00K0.00%
Sigma Planning Corp12,900$3.00K0.00%
Stratos Wealth Partners, LTD.11,300$3.00K0.00%

Sold out (6)

Institutions that held Talphera, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of TLPH in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Citadel Advisors LLC92,459$27.0K
Millennium Management LLC85,210$24.0K
Edmonds Duncan Registered Investment Advisors, LLC41,000$12.0K
HRT Financial LP27,034$7.00K
Bell & Brown Wealth Advisors, LLC20,000$6.00K
Exane Derivatives1$0